Cargando…

Estimating the Impact of Low Influenza Activity in 2020 on Population Immunity and Future Influenza Seasons in the United States

BACKGROUND: Influenza activity in the 2020–2021 season was remarkably low, likely due to implementation of public health preventive measures such as social distancing, mask wearing, and school closure. With waning immunity, the impact of low influenza activity in the 2020–2021 season on the followin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Kyueun, Jalal, Hawre, Raviotta, Jonathan M, Krauland, Mary G, Zimmerman, Richard K, Burke, Donald S, Roberts, Mark S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743127/ https://www.ncbi.nlm.nih.gov/pubmed/35024374 http://dx.doi.org/10.1093/ofid/ofab607

Ejemplares similares

Impact of Low Rates of Influenza on Next-Season Influenza Infections
por: Krauland, Mary G., et al.
Publicado: (2022)

Agent-based model of the impact of higher influenza vaccine efficacy on seasonal influenza burden
por: Krauland, Mary G., et al.
Publicado: (2022)

Relative Effectiveness of Cell-Based Versus Egg-Based Quadrivalent Influenza Vaccines in Adults During the 2019–2020 Influenza Season in the United States
por: Imran, Mahrukh, et al.
Publicado: (2022)

A Real-World Clinical and Economic Analysis of Cell-Derived Quadrivalent Influenza Vaccine Compared to Standard Egg-Derived Quadrivalent Influenza Vaccines During the 2019–2020 Influenza Season in the United States
por: Divino, Victoria, et al.
Publicado: (2021)

Effectiveness of the Cell-Derived Inactivated Quadrivalent Influenza Vaccine in Individuals at High Risk of Influenza Complications in the 2018–2019 United States Influenza Season
por: Boikos, Constantina, et al.
Publicado: (2021)

Relative Effectiveness of MF59 Adjuvanted Trivalent Influenza Vaccine vs Nonadjuvanted Vaccines During the 2019–2020 Influenza Season
por: Imran, Mahrukh, et al.
Publicado: (2022)

Antibiotic Resistance Patterns and Association With the Influenza Season in the United States: A Multicenter Evaluation Reveals Surprising Associations Between Influenza Season and Resistance in Gram-Negative Pathogens
por: Gupta, Vikas, et al.
Publicado: (2022)

Additional Burden Averted in the United States From Use of MF59-Adjuvanted Seasonal Influenza Vaccine Compared With Standard Seasonal Influenza Vaccine Among Adults ≥65 Years
por: McGovern, Ian, et al.
Publicado: (2023)

Interim Estimates of 2019–20 Seasonal Influenza Vaccine Effectiveness — United States, February 2020
por: Dawood, Fatimah S., et al.
Publicado: (2020)

Influenza Vaccine Effectiveness in the United States During 2012–2013: Variable Protection by Age and Virus Type
por: McLean, Huong Q., et al.
Publicado: (2015)

Relative Effectiveness of the Cell-Based Quadrivalent Influenza Vaccine in Preventing Cardiorespiratory Hospitalizations in Adults Aged 18–64 Years During the 2019–2020 US Influenza Season
por: Imran, Mahrukh, et al.
Publicado: (2023)

Interim Adjusted Estimates of Seasonal Influenza Vaccine Effectiveness — United States, February 2013
por: Jackson, Lisa, et al.
Publicado: (2013)

Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2015
por: Flannery, Brendan, et al.
Publicado: (2015)

Estimation of the Lifetime Quality-Adjusted Life Years (QALYs) Lost Due to Syphilis Acquired in the United States in 2018
por: Lee, Kyueun, et al.
Publicado: (2022)

Estimated Influenza Illnesses and Hospitalizations Averted by Influenza Vaccination — United States, 2012–13 Influenza Season
por: Bresee, Joseph, et al.
Publicado: (2013)

The Estimated Lifetime Quality-Adjusted Life-Years Lost Due to Chlamydia, Gonorrhea, and Trichomoniasis in the United States in 2018
por: Li, Yunfei, et al.
Publicado: (2023)

Seasonal Influenza Forecasting in Real Time Using the Incidence Decay With Exponential Adjustment Model
por: Nasserie, Tahmina, et al.
Publicado: (2017)

Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2013
por: Jackson, Lisa, et al.
Publicado: (2013)

The Impact of Influenza Vaccination on Antibiotic Use in the United States, 2010–2017
por: Klein, Eili Y, et al.
Publicado: (2020)

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2020–21 Influenza Season
por: Grohskopf, Lisa A., et al.
Publicado: (2020)

Viral infections in outpatients with medically attended acute respiratory illness during the 2012–2013 influenza season
por: Zimmerman, Richard K, et al.
Publicado: (2015)

Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018–2019 and 2019–2020 calculated using a retrospective test-negative design
por: Zimmerman, Richard K., et al.
Publicado: (2023)

Healthcare-Seeking Behavior for Respiratory Illness Among Flu Near You Participants in the United States During the 2015–2016 Through 2018–2019 Influenza Seasons
por: Baltrusaitis, Kristin, et al.
Publicado: (2020)

Estimated Influenza Illnesses and Hospitalizations Averted by Vaccination — United States, 2013–14 Influenza Season
por: Reed, Carrie, et al.
Publicado: (2014)

Invasive Haemophilus influenzae Disease in Adults ≥65 Years, United States, 2011
por: Blain, Amy, et al.
Publicado: (2014)

Decline in Seasonal Influenza Vaccine Effectiveness With Vaccination Program Maturation: A Systematic Review and Meta-analysis
por: Okoli, George N, et al.
Publicado: (2021)

Interim Estimates of 2013–14 Seasonal Influenza Vaccine Effectiveness — United States, February 2014
por: Flannery, Brendan, et al.
Publicado: (2014)

Determination of Eligibility for Influenza Research: A Clinical Informatics Approach
por: Silveira, Fernanda P, et al.
Publicado: (2019)

Influenza Circulation in United States Army Training Camps Before and During the 1918 Influenza Pandemic: Clues to Early Detection of Pandemic Viral Emergence
por: Chertow, Daniel S., et al.
Publicado: (2015)

Interim Estimates of 2017–18 Seasonal Influenza Vaccine Effectiveness — United States, February 2018
por: Flannery, Brendan, et al.
Publicado: (2018)

Interim Estimates of 2016–17 Seasonal Influenza Vaccine Effectiveness — United States, February 2017
por: Flannery, Brendan, et al.
Publicado: (2017)

Interim Estimates of 2018–19 Seasonal Influenza Vaccine Effectiveness — United States, February 2019
por: Doyle, Joshua D., et al.
Publicado: (2019)

Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness
por: Rolfes, Melissa A., et al.
Publicado: (2018)

Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011–2012 to 2016–2017
por: Gaglani, Manjusha, et al.
Publicado: (2020)

Estimation of Seasonal Influenza Attack Rates and Antibody Dynamics in Children Using Cross-Sectional Serological Data
por: Minter, Amanda, et al.
Publicado: (2020)

Influenza Hospitalizations Among American Indian/Alaska Native People and in the United States General Population
por: Gounder, Prabhu P., et al.
Publicado: (2014)

902. Incidence of Influenza-Related Medical Encounters Among Adults in The United States During the 2015-2020 Influenza Seasons
por: McGovern, Ian, et al.
Publicado: (2023)

Influenza Vaccine Effectiveness in the United States During the 2016–2017 Season
por: Flannery, Brendan, et al.
Publicado: (2017)

Coronavirus disease 2019 (COVID-19) Versus Influenza in Hospitalized Adult Patients in the United States: Differences in Demographic and Severity Indicators
por: Talbot, H Keipp, et al.
Publicado: (2021)

Effects of Prior Influenza Exposure on Immunogenicity of Influenza Vaccine
por: Cao, Jia-Qian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fe5glh738t55rtsiunv9g23lkc